Speaker Profile
Nadia Harbeck

Nadia Harbeck MD, PhD

Obstetrics and Gynecology
Munich, Bavaria, Germany

Connect with the speaker?

Dr. Nadia Harbeck is director of the Breast Center and holds the chair for conservative oncology in the Department of Obstetrics and Gynecology at Ludwig Maximilian University (LMU) Hospital, Munich, Germany. She received her medical degree from LMU, then obtained her specialist training in obstetrics and gynecology at the Technical University of Munich.

Prof Harbeck is a member of the European Society for Medical Oncology (ESMO) executive board, the ESMO director of education (2023–2025), and subject editor of the ESMO Breast Cancer Guidelines (since 2022). She is a member of the American Society of Clinical Oncology (ASCO) annual meeting educational committee (2022–2025) and a member of the expert panel issuing the German Gynecological Oncology Group (AGO) recommendations for breast cancer therapy. She is co-director of the West German Study Group. From 2009–2015, she served on the European Organisation for Research and Treatment of Cancer (EORTC) executive board as chair of the Translational Research Division. Prof Harbeck is a principal investigator or steering committee member of numerous breast cancer trials, particularly with novel targeted compounds and individualized treatment strategies. She has a strong interest in eHealth and is a co-developer of the international digital patient diary CANKADO.

Prof Harbeck is one of the most frequently cited clinical researchers worldwide (Highly Cited Researcher 2021, 2022, 2023). She has authored more than 665 papers in peer-reviewed journals (h–index 97) and is coordinating editor-in-chief of Breast Care. She is the ESMO co-director of the annual EORTC-ESMO-AACR (American Association for Cancer Research) Methods in Clinical Cancer Research Workshop and a panel member of several international breast cancer consensus conferences.

Prof Harbeck is the recipient of the 2023 German Cancer Award and the 2020 ESMO Lifetime Achievement Award. She has also received several additional recognitions for her clinical and translational research, such as the 2021 UPO Award for Women in Academy and Research, the 2015 Bavarian Cancer Patient Award, the 2012 Claudia von Schilling Award, the 2008 European Breast Cancer Conference Award, the 2002 AGO Schmidt-Matthiesen Award, a 2001 AACR Award, and the 2001 ASCO Fellowship Merit Award for the highest-ranking abstract.

EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)